These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 24408121

  • 41. Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T, Amamiya N, Ochi A, Tsuruta Y, Shimizu A, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.
    Clin Exp Nephrol; 2011 Oct; 15(5):700-707. PubMed ID: 21625892
    [Abstract] [Full Text] [Related]

  • 42. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
    Tan L, Tang Y, Peng W, Mathew BS, Qin W.
    Kidney Blood Press Res; 2018 Oct; 43(4):1333-1343. PubMed ID: 30099439
    [Abstract] [Full Text] [Related]

  • 43. Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study.
    Guo Y, Shi S, Zhao J, Wang C, Liu Z, Fu S, Chen N, Li G, Wang L, Ni Z, Zhang H, Lai L, Lv J, Zhang H.
    Ren Fail; 2024 Dec; 46(2):2398826. PubMed ID: 39248402
    [Abstract] [Full Text] [Related]

  • 44. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y, Sun L, Zhou S, Xu Q, Xu Q, Liu D, Liu L, Hu R, Quan S, Xing G.
    Kidney Blood Press Res; 2018 Dec; 43(2):639-650. PubMed ID: 29698975
    [Abstract] [Full Text] [Related]

  • 45. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
    [Abstract] [Full Text] [Related]

  • 46. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X, Ma F, Bai M, Wang Y, Jia Q, Dong R, Liu C, Sun S.
    Ren Fail; 2021 Aug 10; 43(1):1180-1187. PubMed ID: 34376108
    [Abstract] [Full Text] [Related]

  • 47. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP, van den Brand JA, Berger SP, Wetzels JF.
    Neth J Med; 2015 Jul 10; 73(6):284-9. PubMed ID: 26228193
    [Abstract] [Full Text] [Related]

  • 48. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jul 10; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 49. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 Jul 10; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 50. Individual effect of renin-angiotensin system inhibition and corticosteroid therapy in IgA glomerulonephritis: results of a pilot study.
    Kim MJ, Hopfer H, Koller MT, Giannini O, Mihatsch MJ, Mayr M.
    Clin Nephrol; 2010 Feb 10; 73(2):122-30. PubMed ID: 20129019
    [Abstract] [Full Text] [Related]

  • 51. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.
    Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC.
    J Am Soc Nephrol; 2017 Apr 10; 28(4):1306-1313. PubMed ID: 27821627
    [Abstract] [Full Text] [Related]

  • 52. Use of renin-angiotensin inhibitors in people with renal artery stenosis.
    Evans KL, Tuttle KR, Folt DA, Dawson T, Haller ST, Brewster PS, He W, Jamerson K, Dworkin LD, Cutlip DE, Murphy TP, D'Agostino RB, Henrich W, Cooper CJ.
    Clin J Am Soc Nephrol; 2014 Jul 10; 9(7):1199-206. PubMed ID: 24903387
    [Abstract] [Full Text] [Related]

  • 53. [IgA nephropathy - prognostic factors and treatment].
    Wieliczko M, Dylewska M.
    Wiad Lek; 2016 Jul 10; 69(5):707-710. PubMed ID: 28033590
    [Abstract] [Full Text] [Related]

  • 54. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 10; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.